NIH Funds Research Network Focused on HIV-Infected Youth

Article

The National Institutes of Health has awarded funding for a research network devoted to the health and well-being of adolescents and young adults with HIV or at risk for HIV infection. The awards, up to $24 million in 2016, provide for three research centers and a data coordinating center that will make up the Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN).

“Most new HIV infections occur in young people,” said Bill G. Kapogiannis, MD, network co-director and medical officer at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the NIH institute providing much of the funding for the awards. “Many in this population go a long time before they find out they have HIV and often do not get the care they need.”

As a result, Dr. Kapogiannis said, their health may suffer and they risk passing the virus on to future partners. The purpose of the ATN is to get at-risk youth into care, while at the same time offering them the opportunity to participate in research trials that have the potential to improve their health and the health of others. The newly funded ATN centers will conduct studies aimed at preventing HIV infection among youth. They also will seek to enroll HIV-infected youth into treatment studies to improve their health and prevent transmission to others.

“Many at-risk youth are not aware that they need HIV and STI testing or prevention services,” said Sonia Lee, PhD, network co-director and program officer at NICHD. “ATN studies will focus on helping this population engage with available services and avoid behaviors that increase the risk of HIV infection.”

The awards will support three leadership hubs and a coordinating center. Researchers in the network will conduct research through collaborations within the network and with researchers in other institutions. Researchers in each leadership hub will form relationships with clinical sites in urban centers throughout the United States that have expertise in conducting research studies and in providing care for HIV-infected youth.

The principal investigators and the hubs they lead are:
•Mary Jane Rotheram-Borus, PhD, University of California, Los Angeles
•Lisa Hightow-Weidman, MD, University of North Carolina, Chapel Hill; Patrick Sullivan, MD, Emory University, Atlanta
•Sylvie Naar-King, PhD, Wayne State University, Detroit; Bonita Stanton, PhD, Seton Hall University, South Orange, New Jersey; Jeffrey Parsons, PhD, Hunter College, New York City

Myra Carpenter, PhD, and Michael Hudgens, PhD, will serve as co-principal investigators for the coordinating center at University of North Carolina, Chapel Hill. The center will serve as the central resource for network communications, cataloging of biosamples, and data management.

Additional funding for the ATN will be provided by the NIH Office of AIDS Research. Other NIH institutes that will collaborate with the ATN include the National Institute of Mental Health, the National Institute on Drug Abuse, and the National Institute on Minority Health and Health Disparities.

Source: National Institutes of Health (NIH):

Related Videos
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Rare Disease Month: An Infection Control Today® and Contagion® collaboration.
Vaccine conspiracy theory vector illustration word cloud  (Adobe Stock 460719898 by Colored Lights)
Rare Disease Month: An Infection Control Today® and Contagion® collaboration.
Related Content